2024 ICD-10-CM Diagnosis Code C32

by

Malignant neoplasm of larynx

  • C32 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2024 edition of ICD-10-CM C32 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C32 – other international versions of ICD-10 C32 may differ.

Use Additional

  • code to identify:
  • alcohol abuse and dependence (F10.-)
  • exposure to environmental tobacco smoke (Z77.22)
  • exposure to tobacco smoke in the perinatal period (P96.81)
  • history of tobacco dependence (Z87.891)
  • occupational exposure to environmental tobacco smoke (Z57.31)
  • tobacco dependence (F17.-)
  • tobacco use (Z72.0)

The following code(s) above C32 contain annotation back-references

 that may be applicable to C32:

  • C00-D49  Neoplasms
  • C30-C39  Malignant neoplasms of respiratory and intrathoracic organs

Clinical Information

  • A primary or metastatic malignant tumor involving the larynx. The majority are carcinomas.

Code History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Code annotations containing back-references to C32:

error: Content is protected !!